NSE › Healthcare

Haleos Labs Limited (HALEOSLABS)

NSE · Healthcare · Biotechnology

₹1,589.00+3.29%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹75 cr

Revenue YoY

-7.4%

Net profit

₹43.6 lakh

Profit YoY

-85.3%

EPS

₹11.56

EPS estimate

₹16.91

Net margin

0.6%

EPS came in at 11.56 against a street estimate of 16.91 — a miss of 31.6%.

Key statistics

Market cap

₹476 cr

P/E

27.5

Forward P/E

0.0

P/B

2.17

Book value

₹705.78

EPS (TTM)

₹57.25

Dividend yield

0.10%

52-week high

₹1,774.00

52-week low

₹1,065.66

50-day MA

₹1,507.21

200-day MA

₹1,357.71

Beta

0.36

Shareholding

Promoters

74.97%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Haleos Labs Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Cipla Limited Zydus Lifesciences Limited Lupin Limited Max Healthcare Institute Limited Mankind Pharma Ltd Laurus Labs Limited Lenskart Solutions Ltd Dr. Reddy's Laboratories Limited

Data updated 2026-08-05.